Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Letter"
topic_facet:"Antibodies, Monoclonal, Humanized"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Letter%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22&lookfor=%221468-2060%22&type=ISN
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Letter%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22&lookfor=%221468-2060%22&type=ISN
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Letter%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22&lookfor=%221468-2060%22&type=ISN
PubPharm (135)
1
Low plasma belimumab levels as an indicator of poor adherence to belimumab in patients with systemic lupus erythematosus
enthalten in:
Annals of the rheumatic diseases
| 2024
von
Trefond, L.
|
Zahr, N.
|
Lhote, R.
| +11
Wird geladen...
2
Obinutuzumab in patients with Sjogren's disease immunised against rituximab
enthalten in:
Annals of the rheumatic diseases
| 2024
von
Pezot, M.
|
Nocturne, G.
|
Belkhir, R.
| +5
Wird geladen...
3
IL-17A inhibitor-induced leucocytoclastic vasculitis is responsive to IL-23 blockade in a psoriatic arthritis patient
enthalten in:
Annals of the rheumatic diseases
| 2024
von
Binod, K.
|
Jabbour, A.
|
Poudel, P.
| +2
Wird geladen...
4
Correspondence on 'Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis : 16-week results from a randomized, placebo-controlled, phase 3 trial'
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Zhao, Y.
|
Huang, J.
CommentOn: Ann Rheum Dis. 2021 Aug;80(8):1014-1021. - PMID 33827787
Wird geladen...
5
Response to : 'Correspondence on 'Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial'' by Zhao and Huang
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Wei, J.
|
Kim, T.
|
Kishimoto, M.
| +3
CommentOn: Ann Rheum Dis. 2021 Aug;80(8):1014-1021. - PMID 33827787
Wird geladen...
6
Transplacental passage of belimumab during pregnancy and follow-up of a child exposed in utero
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Bitter, H.
|
Warren, D.
|
Bolstad, N.
| +2
Wird geladen...
7
Two cases with new onset of ANCA-positive eosinophilic granulomatosis with polyangiitis under treatment with dupilumab : coincidence or causality?
enthalten in:
Annals of the rheumatic diseases
| 2023
von
von Deimling, M.
|
Koehler, T.
|
Frye, B.
| +2
Wird geladen...
8
Correspondence on 'Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever : results from the randomised phase III CLUSTER trial'
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Satış, H.
|
Aydemir, E.
|
İzmirlioğlu, K.
| +1
CommentOn: Ann Rheum Dis. 2020 Oct;79(10):1362-1369. - PMID 32571870
Wird geladen...
9
Correspondence on 'Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort' by Micheroli et al
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Huang, J.
|
Leong, P.
|
Wei, J.
CommentOn: Ann Rheum Dis. 2020 Sep;79(9):1203-1209. - PMID 32581090
Wird geladen...
10
Response to : 'Correspondence on 'Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort' by Micheroli et al' by Huang et al
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Ciurea, A.
|
Micheroli, R.
CommentOn: Ann Rheum Dis. 2020 Sep;79(9):1203-1209. - PMID 32581090
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Letter
Filter aufheben
Thema: Antibodies, Monoclonal, Humanized
Medienart
135
Aufsätze
126
E-Artikel
126
E-Ressourcen
9
Gedruckte Aufsätze
Zeitschriftentitel
135
Annals of the rheumatic diseases
Thema
Antibodies, Monoclonal, Humanized
Letter
64
Comment
54
I031V2H011
54
tocilizumab
53
Antirheumatic Agents
33
Antibodies, Monoclonal
30
Research Support, Non-U.S. Gov't
26
Adalimumab
26
Case Reports
26
FYS6T7F842
23
Tumor Necrosis Factor-alpha
22
treatment
20
inflammation
19
biological therapy
17
cytokines
16
Immunosuppressive Agents
14
Treatment
13
Rheumatoid Arthritis
12
DMARDs (biologic)
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
61
2020-
61
2010-2019
13
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
135
Englisch
Haven't found what you're looking for?
Wird geladen...